KLA Corporation Work in process increased by 11.2% to $929.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.0%, from $808.56M to $929.60M. Over 4 years (FY 2021 to FY 2025), Work in process shows an upward trend with a 16.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $453.43M | $426.86M | $427.97M | $441.56M | $451.78M | $527.36M | $477.59M | $575.08M | $578.86M | $635.05M | $621.41M | $674.19M | $700.90M | $736.88M | $768.13M | $808.56M | $833.93M | $859.78M | $836.17M | $929.60M |
| QoQ Change | — | -5.9% | +0.3% | +3.2% | +2.3% | +16.7% | -9.4% | +20.4% | +0.7% | +9.7% | -2.1% | +8.5% | +4.0% | +5.1% | +4.2% | +5.3% | +3.1% | +3.1% | -2.7% | +11.2% |
| YoY Change | — | — | — | — | -0.4% | +23.5% | +11.6% | +30.2% | +28.1% | +20.4% | +30.1% | +17.2% | +21.1% | +16.0% | +23.6% | +19.9% | +19.0% | +16.7% | +8.9% | +15.0% |
| % of Inventories | 28.8% | 24.9% | 23.4% | 22.3% | 21.0% | 21.9% | 18.8% | 20.9% | 20.1% | 21.1% | 20.5% | 22.4% | 23.1% | 23.7% | 25.2% | 25.6% | 26.0% | 26.1% | 25.5% | 27.0% |
| Share Change | — | -3.9pp | -1.5pp | -1.1pp | -1.2pp | +0.9pp | -3.1pp | +2.1pp | -0.8pp | +1.0pp | -0.7pp | +2.0pp | +0.7pp | +0.6pp | +1.5pp | +0.4pp | +0.3pp | +0.1pp | -0.6pp | +1.6pp |